Unichem rises on getting USFDA’s nod for Cetirizine Hydrochloride, Pseudoephedrine Hydrochloride Tablets

07 May 2019 Evaluate

Unichem Laboratories is currently trading at Rs. 186.80, up by 0.45 points or 0.24% from its previous closing of Rs. 186.35 on the BSE.

The scrip opened at Rs. 186.20 and has touched a high and low of Rs. 189.95 and Rs. 185.50 respectively. So far 3519 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 288.40 on 08-May-2018 and a 52 week low of Rs. 182.00 on 11-Oct-2018.

Last one week high and low of the scrip stood at Rs. 192.95 and Rs. 185.50 respectively. The current market cap of the company is Rs. 1314.76 crore.

The promoters holding in the company stood at 50.64%, while Institutions and Non-Institutions held 9.41% and 39.95% respectively.

Unichem Laboratories has received tentative ANDA approval from the United States Food and Drug Administration (USFDA) for Unichem's Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride Extended-Release Tablets USP, 5 mg/120 mg (OTC) to market a generic version of Johnson and Johnson Consumer Inc's Zyrtec-D 12 Hour (Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride, 5mg/120 mg) Extended Tablets.

The product will be commercialized from Unichem’s Goa Plant on receipt of final approval. 

Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world.


Unichem Lab Share Price

444.55 -1.10 (-0.25%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×